EN DE
Watch Precision Optics Corporation, Inc. Common stock for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Precision Optics Corporation, Inc. (POCI) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Precision Optics Corporation, Inc. stock $4.54, price $5.08, that is 10.6% below the price, quality 34 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US

PO Precision Optics Corporation, Inc. logo Thin data Nov 10, 2026

Precision Optics Corporation, Inc.

POCI · US
Expensive, weak quality

Our calculation puts a fair price 11% below what the stock costs today.

Low debt
Revenue last quarter +42% vs. a year ago.
Expensive Growth (revenue 5y +24.2 %/yr in USD)
Fair value $4.54 · Overvalued
Quality 34/100
Loss-making · -11.5% net margin (TTM)
Negative free cash flow
Trails peers (3/10)
Narrow moat 7/100 · thin data
Thin data
Estimate
Watch Precision Optics Corporation, Inc. Common stock for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$7.65 $1.95 Fair Value $4.54 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $1.95 – $7.65 · fair‑value band $3.41 – $5.68 · the $5.08 price screens above the $4.54 fair value. As of Nov 10, 2026.

Follow Precision Optics Corporation, Inc. Common stock in your weekly email

Every Wednesday you see whether Precision Optics Corporation, Inc. Common stock is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.

Show moreShow less

The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.

It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.

Stock analysis

Precision Optics Corporation, Inc. (POCI) currently trades at $5.08, while our estimate is $4.54, 11% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $3.41 (bear) to $5.68 (bull), the price of $5.08 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 34/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Precision Optics Corporation, Inc. Common stock reported revenue of $31.5M in FY2026 versus $15.7M in FY2022, a compound +19.1%/yr. Reported net income was −$3.6M in FY2026.

Key figures

Market cap $55.1M Micro · P/S ratio 1.60 · EPS (TTM) $−0.4300 · Net margin −11.5% · Return on equity −22.3% · Return on assets (EBIT) −13.3% (5-year average) · Operating margin −1.2% · Revenue (TTM) $31.5M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 7 out of 100 (low confidence).

What moves the price

The share trades about 15% below its 52-week high and 30% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −11%, POCI screens cheaper than that median.

Fair Value

Bear $3.41 Fair Value $4.54 Bull $5.68
Price $5.08 · Downside -10.6%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 34/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 21
How much profit the company makes from its sales and capital
Quality Growth 80
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 73
Debt, balance sheet and risk of trouble
Investment 38
Does it invest with discipline instead of growing at any price?
Low Volatility 60
How calm the share price moves, does not count
Price momentum 59
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 58
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

  • BuyJoseph Norman ForkeyChief Executive Officer, Director1,388 shares at $3.60$4,997Mar 30, 2026
  • BuyJoseph TrautChief Operating Officer41,666 shares at $3.60$149,998Mar 30, 2026
  • BuyWayne M CollChief Financial Officer20,833 shares at $3.60$74,999Mar 30, 2026

Plus 5 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 10, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+65.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.2%
Start year 2021 (pandemic). Over 10 years: +23.2% a year
Revenue growth 35 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−8.5% (2021) → −11.1% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

POCI screens overvalued: fair value 11% below the price. Compare with Intuitive Surgical, Inc →

Compare Precision Optics Corporation, Inc. Common stock with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 196 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 34 · Bottom 25%
Fair Value upside −10.6% · Below median
Profitability
Return on assets −11.2% · Bottom 25%
Net margin (12 months) −11.5% · Bottom 25%
Operating margin (12 months) −1.2% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 42.0% · Top 25%
Balance sheet
Debt / equity 0.04× · Below median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B 2.71× · Pricier than median
P/S (12 months) 1.75× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)19 · sector 21
FUTURE (revenue growth)100 · sector 40
PAST (return on equity)0 · sector 26
HEALTH (low debt)98 · sector 96
DIVIDEND (yield)0 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $90.08 $131.27 +46% vs POCI
EssilorLuxottica Société anonyme EL €187.60 €196.22 +5% vs POCI
Intuitive Surgical, Inc ISRG $450.04 $353.90 −21% vs POCI
Medline Inc MDLN $40.91 $28.59 −30% vs POCI
Alcon Inc ALC CHF 61.88 CHF 34.06 −45% vs POCI
Becton, Dickinson and Company BDX $212.61 $97.80 −54% vs POCI
Straumann Holding STMN CHF 106.85 CHF 45.50 −57% vs POCI
West Pharmaceutical Services, Inc WST $412.55 $139.22 −66% vs POCI
Sartorius Stedim Biotech S.A DIM €223.40 €54.82 −75% vs POCI
Sartorius Aktiengesellschaft SRT €227.00 €42.50 −81% vs POCI

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Precision Optics Corporation, Inc. Common stock: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Precision Optics Corporation, Inc. Common stock Fair Value". https://www.fairvalue-calculator.com/stock/POCI

Frequently asked questions

Is Precision Optics Corporation, Inc. (POCI) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $4.54 versus a price of $5.08, about 11% lower (overvalued).
What is the fair value of POCI?
Our estimate for Precision Optics Corporation, Inc. is $4.54 (as of Nov 10, 2026), built from audited fundamentals. The current price: $5.08.
What is the quality score of POCI?
Precision Optics Corporation, Inc. has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Precision Optics Corporation, Inc. (POCI)?
Our calculated price target is the estimate of $4.54 (as of Nov 10, 2026). Cautious scenario $3.41, optimistic scenario $5.68. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Precision Optics Corporation, Inc. Common stock stock forecast for 2026?
Our estimate puts fair value at $4.54, about 11% lower versus a price of $5.08 (overvalued). Cautious scenario $3.41, optimistic scenario $5.68. The calculation is refreshed regularly with new filings.
What is the revenue of Precision Optics Corporation, Inc. (POCI)?
Precision Optics Corporation, Inc. reported trailing-twelve-month revenue of about $31.5M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Precision Optics Corporation, Inc. (POCI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Precision Optics Corporation, Inc. it is $4.54 per share (as of Nov 10, 2026), against a price of $5.08.
Is Precision Optics Corporation, Inc. Common stock stock overvalued or undervalued in 2026?
As of Nov 10, 2026, POCI trades above its calculated fair value: price $5.08, fair value $4.54, a gap of about −11% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of POCI?
No. The price is what the market pays today ($5.08); the fair value is what the company's own numbers justify ($4.54). For Precision Optics Corporation, Inc. the two are $0.5400 per share apart. That gap is exactly why we show both numbers side by side.
How much is Precision Optics Corporation, Inc. Common stock worth?
The market values Precision Optics Corporation, Inc. at about $55.1M (market capitalisation, as of Nov 10, 2026). Per share that is $5.08; our models calculate a fair value of $4.54 per share.
What do the bullish and bearish scenarios say about POCI?
Our models span a range for Precision Optics Corporation, Inc.: cautious scenario $3.41, base $4.54, optimistic $5.68 per share (as of Nov 10, 2026, price $5.08). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Precision Optics Corporation, Inc. (POCI)?
Balance-sheet figures for Precision Optics Corporation, Inc. (as of Nov 10, 2026): return on equity −22.3%, debt of 0.04 per unit of equity. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is POCI from its 52-week high?
Precision Optics Corporation, Inc. trades at $5.08, about 15% below its 52-week high of $5.96 and 30% above the low of $3.90 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of $4.54 is for.
Which stocks are comparable to Precision Optics Corporation, Inc. Common stock?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Precision Optics Corporation, Inc. Common stock stock attractive at the current price?
The data as of Nov 10, 2026: price $5.08, calculated fair value $4.54 (−11%), Quality Score 34/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Precision Optics Corporation, Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Precision Optics Corporation, Inc. (POCI)?
The closing price on Nov 10, 2026 was $5.08. Our estimate is $4.54, about 11% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Precision Optics Corporation, Inc. Common stock right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Precision Optics Corporation, Inc.

How large is the market capitalisation of Precision Optics Corporation, Inc. (POCI)?
The market capitalisation of Precision Optics Corporation, Inc. is $55.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Precision Optics Corporation, Inc. (POCI)?
The price-to-sales ratio of Precision Optics Corporation, Inc. is 1.60 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Precision Optics Corporation, Inc. (POCI)?
Earnings per share at Precision Optics Corporation, Inc. are $−0.4300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Precision Optics Corporation, Inc. (POCI)?
The net margin of Precision Optics Corporation, Inc. is −11.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Precision Optics Corporation, Inc. (POCI)?
The return on equity (ROE) of Precision Optics Corporation, Inc. is −22.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Precision Optics Corporation, Inc. (POCI)?
On an EBIT basis the return on assets of Precision Optics Corporation, Inc. is −13.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Precision Optics Corporation, Inc. (POCI)?
The operating margin of Precision Optics Corporation, Inc. is −1.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Precision Optics Corporation, Inc. (POCI)?
Revenue at Precision Optics Corporation, Inc. is growing +42.0% versus a year earlier (3y avg +14.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Precision Optics Corporation, Inc. (POCI) generate?
The free cash flow of Precision Optics Corporation, Inc. is −$2.0M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Precision Optics Corporation, Inc. (POCI) hold?
Precision Optics Corporation, Inc. holds more cash than debt, $5.8M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Precision Optics Corporation, Inc. Common stock in the live analysis

One click puts Precision Optics Corporation, Inc. Common stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.